Leadership

Executive Team

Paramit's executive management team shares an obsession for correctness, innovation, common sense, and integrity that permeates the company culture and drives Paramit's ability to manufacture quality products. These experienced and dedicated senior managers pride themselves on understanding and appreciating the intricacies of every aspect of the medical manufacturing business. Their hands-on approach gives them direct knowledge of the challenges involved in the building of highly complex medical devices and instruments and enables them to instill Paramit's values in every employee.

	Billoo Rataul, President and CEO Billoo co-founded Paramit in 1990, and has served as the chief architect for Paramit's development of custom solutions to optimize operations. Prior to Paramit, Billoo spent five years at LTX-Trillium in both engineering and management positions. Billoo has a BSME from BIT (India) and an MS in Manufacturing Systems from Purdue University.		Tom La Rose, Chief Financial Officer Tom joined Paramit in 2005 as Chief Financial Officer. He oversees the staff and systems for the day-to-day financial operations, represents Paramit to the financial community, and develops the company's financial reporting infrastructure. Before joining Paramit, Tom spent over 15 years in contract manufacturing as a controller and CFO. Tom has a BS in Accounting and MBA from Santa Clara University.
	Carl Chun, Vice President of Engineering and Quality Carl joined Paramit in 1992 as Director of Test Engineering. Since then, he has built our test infrastructure, including both test development and all levels of test and reliability, into a core company strength. Prior to joining Paramit, Carl spent seven years at LTX-Trillium in both test engineering and test development positions. Carl has a BSEE from Santa Clara University.		Jim Creel, Vice President of Sales and Marketing Jim joined Paramit in 2010. He brings a structured and strategic approach to Paramit's sales and marketing that parallels our operational and engineering strengths. Jim has served the technology manufacturing industry for 15years as a VP of Sales, VP of Operations, and, most recently, as Division General Manager for Flextronics. Previously, he led technology account management and consulting for the world's largest custom market research firm as Senior VP of Global Account Operations. Jim has a BBA from Tarleton State University.
	Francesco Grieco, Vice President of Operations Francesco joined Paramit in 2002 as Manager Manufacturing Systems and he has designed methods, processes and systems to increase productivity throughout the company. Francesco is now VP of Operations with the focus of implementing the vision of an integrated and efficient Manufacturing System. Prior to Paramit, Francesco worked for Alitalia. Francesco has a BS in Industrial Engineering from Tor Vergata University of Rome.

Board of Directors

Paramit's board of directors is comprised of top executives in global business as well as the medical field. They help us understand the challenges and opportunities of ongoing FDA guideline development, the market implications of new technologies, and the adoption path of those technologies.

George E. Aitken-Davies, Managing Director, Altaris Capital Partners, LLC

A founding partner of Altaris Capital Partners, LLC, an investment firm focused exclusively on companies operating in the healthcare industry, George is responsible for sourcing, analyzing, executing, and monitoring private equity transactions and he serves on the board of directors for a number of Altaris portfolio companies. Prior to Altaris, George worked at Merrill Lynch where he was a member of the firm's private equity and healthcare investment banking group. With a Masters in Molecular and Cellular Biochemistry from the University of Oxford, George investigated the metabolism of bovine prion protein for his research dissertation.

Bernie Lyons, President and Chief Executive Officer, Direct Flow Medical, Inc.

Bernie is President and CEO of Direct Flow Medical, Inc., a medical device company specializing in aortic valve implants. Throughout his career Bernie has held senior level management positions at a number of medical device companies, including Vasca, Inc. (President and CEO), a maker of subcutaneous vascular access ports for hemodialysis treatment, CardioClasp, Inc. (President and CEO), a start-up focused on the treatment of congestive heart failure, and Boston Scientific Corporation, a large manufacturer of diagnostic and therapeutic products. Bernie has been an Instructor in Surgery at Dartmouth Medical School and Adjunct Assistant Professor at the Thayer School of Engineering at Dartmouth College. He earned a Ph.D. in Cancer Biology from Stanford University School of Medicine.

Daniel G. Tully, Managing Director, Altaris Capital Partners, LLC

Daniel is also a founding partner of Altaris Capital Partners, LLC, a healthcare investment firm, where he serves on the board of directors for several Altaris portfolio companies. Daniel currently serves as vice chairman of the board of the Hospital for Special Surgery in New York as well. Prior to the formation of Altaris, Daniel held various positions with Merrill Lynch, including serving as the firm's global head of healthcare equity capital markets. Daniel received a B.S. in Economics from the University of Pennsylvania, Wharton Undergraduate Program.